Buyer profile
IKK classic
Every award we hold where this buyer named a supplier, in DED21, Germany, from 15 Nov 2010 to 2 Oct 2026— with what is open now and what ends soon.
Awards
523
naming a supplier
Attributed value
€442.3m
167 shared, unvalued
Suppliers
584
awarded to
Active
2010–2026
first to latest award
Open right now
Notices from this buyer still open for bids, soonest deadline first. Each links to the buyer's own notice; deadlines are as published.
Contracts ending soon
Awards whose notice published a contract end date in the next eighteen months, among awards published in the last 5 years. A notice without an end date is not listed — nothing is inferred.
- Dr. Falk Pharma GmbH, BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft), H e x a l Aktiengesellschaft, Zentiva Pharma GmbH, BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH), ratiopharm GmbH, TEVA GmbH, BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH), Heunet Pharma GmbH, BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH), STADAPHARM GmbH, neuraxpharm Arzneimittel GmbH, TAD Pharma GmbH, Cipla Europe NV, GALENpharma GmbH, ETHYPHARM GmbH, Berlin-Chemie AG, Nordmark Pharma GmbH, Dipharma Arzneimittel GmbH, Glenmark Arzneimittel GmbH, PUREN Pharma GmbH & Co. KG, Viatris Healthcare GmbH, Zweigniederlassung Bad Homburg, G.L. Pharma GmbH vertreten durch G.L. Pharma Deutschland GmbH, Micro Labs GmbH, Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH, Abdi Farma GmbH, acis Arzneimittel GmbH, Basics GmbH, axunio Pharma GmbH, Dexcel Pharma GmbH, Holsten Pharma GmbH, Luye Pharma AG, BIOCON PHARMA MALTA I LIMITED, Sanofi-Aventis Dtl. GmbH, Bluefish Pharma GmbH, Amarox Pharma GmbH, Aristo Pharma GmbH, betapharm Arzneimittel GmbH, Medical Valley Invest AB, Abanta Pharma GmbH, 089Pharm GmbH, Accord Healthcare SL vertreten durch Accord Healthcare GmbH, Devatis GmbH, mibe GmbH Arzneimittel, Otsuka Pharma GmbH, BG Libra-Pharm / Grünenthal GmbH (Grünenthal GmbH, Libra-Pharm GmbH), Libra-Pharm GmbH, AAA-Pharma GmbH, Pierre Fabre Pharma GmbH, Denk Pharmaawarded 27 Jul 2024ted-eu
- BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft), Hexal AG, Dexcel Pharma GmbH, TAD Pharma GmbH, BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH), STADAPHARM GmbH, Glenmark Arzneimittel GmbH, Zentiva Pharma GmbH, Bluefish Pharma GmbH, betapharm Arzneimittel GmbH, BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH), Heunet Pharma GmbH, HEC Pharm GmbH, AAA-Pharma GmbH, Holsten Pharma GmbH, Viatris Healthcare GmbH, Zweigniederlassung Bad Homburg, BG Neuraxpharm Hexal GbR (H e x a l Aktiengesellschaft, neuraxpharm Arzneimittel GmbH), neuraxpharm Arzneimittel GmbH, Micro Labs GmbH, BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH), ratiopharm GmbH, TEVA GmbH, HIKMA PHARMA GMBH, ribosepharm division, Amarox Pharma GmbH, PUREN Pharma GmbH & Co. KG, BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH)R, H e x a l Aktiengesellschaft, Dermapharm AG, ETHYPHARM GmbH, G.L. Pharma GmbH vertreten durch G.L. Pharma Deutschland GmbH, Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH, Aristo Pharma GmbH, Exeltis Germany GmbH, mibe GmbH Arzneimittel, axunio Pharma GmbH, Devatis GmbH, Almirall Hermal GmbH, Jenapharm GmbH & Co. KG, Medical Valley Invest AB, Laboratorios Farmacéuticos ROVI S.A. vertreten durch ROVI GmbH, Sanofi-Aventis Dtl. GmbH, Ascend GmbH, BIOCON PHARMA MALTA I LIMITED, Orion Pharma GmbH, Hikma Pharma GmbH, EVER Pharma GmbH, medac Gesellschaft für klinische Spezialpräparate mbH, Penta Arzneimittel GmbH, OmniVision, Medac Gesellschaft für klinische Spezialpräparate m.b.H., Hormosan Pharma Gesellschaft mit beschränkter Haftung, Pfizer Pharma GmbH, Abacus Medicine A/S, Dr. Falk Pharma GmbH, Ferring Arzneimittel GmbHawarded 27 Jul 2024ted-eu
Awards by year
Who they award to
| Supplier | Awards | Value |
|---|---|---|
| betapharm Arzneimittel GmbH | 31 | €491k |
| Glenmark Arzneimittel GmbH | 28 | €738k |
| Hexal AG | 28 | €878k |
| ratiopharm GmbH | 27 | not attributable |
| neuraxpharm Arzneimittel GmbH | 26 | €9.4m |
| 1A Pharma GmbH | 24 | not attributable |
| TAD Pharma GmbH | 24 | €1.9m |
| Gies Dienstleistungen GmbH | 23 | €360k |
| Zentiva Pharma GmbH | 23 | €1.0m |
| ALIUD PHARMA GmbH | 22 | €478k |
What they buy
Selling to them?
Get this buyer's new notices in a daily digest, scored against your own capability — plus the full record behind each award, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. The buyer's published spellings are grouped by case, punctuation and spacing only — this profile holds 2 of them; nothing that could mark a different body is removed, so a council and its housing department, or a trust and its charity, stay separate. An award counts here only where its notice named at least one supplier. Value is attributed only where the notice is explicit: a supplier's own itemised amount, or the whole value where one supplier was named. Awards naming several suppliers without a published split are counted and marked shared, never valued; a framework ceiling is never treated as money a supplier won; nothing is estimated. Every currency is reported separately, never summed. Contract end dates are the ones the notice published, looked for among awards published in the last 5 years. The linked source notice is authoritative.